Samar Mahmoud Mohamed Elbahy
Lecturer
Expression of NCF4 (rs1883112) polymorphism and risk of developing Acute Lymphoblastic Leukemia in Egyptian children
• 2025
Publication Information
Authors
Walid Abdellatif Abdelhalim1, Amira M. N. Abdelrahman1, Adel Marzouk Agha1, Samar Mahmoud Elbahy2, Amr Fathy Mohamed Gad1, Maha M. T. Rashwan1
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Acute lymphoblastic leukemia (ALL) incidence has been linked to different genetic variations. Neutrophil cytosolic factor 4 (NCF4) (rs1883112) single nucleotide polymorphism (SNP) is one of the implicated genetic variations.
Aim: To demonstrate the association between NCF4 (rs1883112) SNP and susceptibility to develop ALL in Egyptian children and its correlation to clinical variables, laboratory parameters, and patient outcomes.
Methods: The study was conducted on 100 ALL patients < 18 years old and 100 healthy controls matched in age and sex. The detection of NCF4 (rs1883112) polymorphism by Taqman real-time PCR was carried out.
Results: The GA and AA genotypes, dominant model, and A allele showed a lower frequency in ALL patients compared to controls (p=0.001, 0.015, 0.001, and 0.009, respectively). The AA genotype was significantly associated with a higher frequency of patients with t(12;21), and those achieved complete remission (p=0.005 and 0.014, respectively). The hazard ratio (HR) of the dominant model was (HR=0.15, p=0.031) for overall survival and (HR=0.24, p=0.012) for disease-free survival by univariate analysis.
Conclusion: Our results suggested that NCF4 (rs1883112) SNP has a significant protective effect against susceptibility to ALL development. Also it is associated with favorable outcomes concerning the overall survival and disease-free survival.
Aim: To demonstrate the association between NCF4 (rs1883112) SNP and susceptibility to develop ALL in Egyptian children and its correlation to clinical variables, laboratory parameters, and patient outcomes.
Methods: The study was conducted on 100 ALL patients < 18 years old and 100 healthy controls matched in age and sex. The detection of NCF4 (rs1883112) polymorphism by Taqman real-time PCR was carried out.
Results: The GA and AA genotypes, dominant model, and A allele showed a lower frequency in ALL patients compared to controls (p=0.001, 0.015, 0.001, and 0.009, respectively). The AA genotype was significantly associated with a higher frequency of patients with t(12;21), and those achieved complete remission (p=0.005 and 0.014, respectively). The hazard ratio (HR) of the dominant model was (HR=0.15, p=0.031) for overall survival and (HR=0.24, p=0.012) for disease-free survival by univariate analysis.
Conclusion: Our results suggested that NCF4 (rs1883112) SNP has a significant protective effect against susceptibility to ALL development. Also it is associated with favorable outcomes concerning the overall survival and disease-free survival.